ASPIRA PATHLAB & DIAGNOSTICS
|
The Current P/E Ratio of ASPIRA PATHLAB & DIAGNOSTICS is 38.61.
| Share Price | ₹95.9 | Jul 21,2026 |
| Market Cap | ₹98.8 Cr | |
| Earnings-TTM | ₹2.6 Cr | TTM-Consolidated Results |
| Price/Earnings | 38.61x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ASPIRA PATHLAB & DIAGNOSTICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹98.8 Cr] as on Jul 21,2026
(/) Earnings [ ₹2.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.61x ]
Thus, for ASPIRA PATHLAB & DIAGNOSTICS , the investors are currently willing to pay 38.61 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ASPIRA PATHLAB & DIAGNOSTICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ASPIRA PATHLAB & DIAGNOSTICS over the last five years.
Historical PE (Price/Earnings) ratio chart of ASPIRA PATHLAB & DIAGNOSTICS
PE Ratio Performance Analysis for ASPIRA PATHLAB & DIAGNOSTICS
- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio for fiscal years ending Mar2025 to Mar2024 averaged 21.69x.
- ASPIRA PATHLAB & DIAGNOSTICS 's operated at median p/e ratio of 43.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio peaked in Mar2025 at 43.37x.
- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ASPIRA PATHLAB & DIAGNOSTICS 's P/E Ratio benchmark against top 10 peers in Hospital & Healthcare Services Industry?
| Peer Comparison (Hospital & Healthcare Services Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ASPIRA PATHLAB & DIAGNOSTICS | 2.56 | 38.61 | 98.8 |
| APOLLO HOSPITALS ENTERPRISE LTD | 1,957.70 | 65.52 | 128,265.0 |
| MAX HEALTHCARE INSTITUTE LTD | 1,442.41 | 74.25 | 107,094.0 |
| FORTIS HEALTHCARE LTD | 1,047.84 | 69.83 | 73,174.3 |
| ASTER DM HEALTHCARE LTD | 464.10 | 152.91 | 70,967.2 |
| NARAYANA HRUDAYALAYA LTD | 816.04 | 50.03 | 40,826.2 |
| GLOBAL HEALTH LTD | 554.07 | 65.06 | 36,050.3 |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 239.40 | 138.70 | 33,205.7 |
| DR LAL PATHLABS LTD | 509.80 | 55.93 | 28,511.0 |
| DR AGARWALS HEALTH CARE LTD | 168.14 | 91.69 | 15,417.0 |
| RAINBOW CHILDRENS MEDICARE LTD | 281.54 | 53.57 | 15,081.6 |
Hospital & Healthcare Services Industry Benchmark (Top 10) PE Analysis vs ASPIRA PATHLAB & DIAGNOSTICS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 38.61x |
| Max industry PE | 152.91x |
| Median industry PE | 65.52x |
| Average industry PE | 77.83x |
You may also like the below Video Courses